Skip to content
Lipocine Inc. logo — company profile

Lipocine Inc.

Founded 1997 United States Salt Lake City, United States 26 employees Post-IPO Equity Total: $66.72M Biotechnology, Pharmaceutical

General Information

Company Name Lipocine Inc.
Founded Year 1997
Location United States Salt Lake City, United States
Founders / Decision Makers
Team member Team member
Employees 26
Industries Biotechnology, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Lipocine Inc.. To contact Lipocine Inc., visit lipocine.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Lipocine Inc. compare?

A PDF of Lipocine Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Lipocine Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Lipocine Inc.

Lipocine Inc. is a specialty pharmaceutical company with a focus on developing and commercializing pharmaceutical products. Founded in 1997 and headquartered in Salt Lake City, Utah, the company has been dedicated to developing drugs based on Hydroance, a drug delivery technology, primarily focusing on creating oral versions of several hormones for both men and women's health. In addition to its lipid-based technology platform, Lipocine Inc. offers non-invasive delivery solutions for small polar organics and macromolecules. Moreover, the company provides custom drugs for pharmaceutical/biotechnology companies. The company recently received a significant $28.70M Post-IPO Equity investment on 26 January 2021.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $28.70M -
26 Jan 2021
Post IPO Equity $38.02M -
01 Aug 2013

Lipocine Inc. Alternatives & Competitors

Lipocine Inc. vs
Quince Therapeutics
Quince Therapeutics United States

Dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases

Post-IPO Equity
25 employees
Biotechnology, Health Care

FAQ About Lipocine Inc.

Lipocine Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. The company develops drugs based on Hydroance, a drug delivery technology. It primarily focuses on developing oral versions of several hormones for use in men and women health. The company’s lipid...
Lipocine Inc. was founded in 1997.
Lipocine Inc. is headquartered in Salt Lake City, United States.
Lipocine Inc. operates in Biotechnology and Pharmaceutical.
Lipocine Inc. has approximately 26 employees.
Lipocine Inc. has completed 2 funding rounds, raising a total of $66.72M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Lipocine Inc. include Quince Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lipocine Inc. and Quince Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Lipocine Inc., https://bouncewatch.com/company/lipocine-inc, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout